Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-cell recognition of melanoma-associated antigens.
Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N, Parmiani G. Castelli C, et al. Among authors: andreola g. J Cell Physiol. 2000 Mar;182(3):323-31. doi: 10.1002/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#. J Cell Physiol. 2000. PMID: 10653598 Review.
Cytokines in cancer therapy.
Parmiani G, Rivoltini L, Andreola G, Carrabba M. Parmiani G, et al. Among authors: andreola g. Immunol Lett. 2000 Sep 15;74(1):41-4. doi: 10.1016/s0165-2478(00)00247-9. Immunol Lett. 2000. PMID: 10996626 Review.
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchianò A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P, Parmiani G. Belli F, et al. Among authors: andreola g. J Clin Oncol. 2002 Oct 15;20(20):4169-80. doi: 10.1200/JCO.2002.09.134. J Clin Oncol. 2002. PMID: 12377960 Clinical Trial.
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.
Laszlo D, Andreola G, Rigacci L, Fabbri A, Rabascio C, Mancuso P, Pruneri G, Radice D, Pinto A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G. Laszlo D, et al. Among authors: andreola g. J Clin Oncol. 2010 May 1;28(13):2233-8. doi: 10.1200/JCO.2009.23.6315. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368573 Clinical Trial.
Rationale for the use of gemcitabine in breast cancer (Review).
Silvestris N, D'Aprile M, Andreola G, Locopo N, Marini L, Crucitta E, De Lena M, Lorusso V. Silvestris N, et al. Among authors: andreola g. Int J Oncol. 2004 Feb;24(2):389-98. doi: 10.3892/ijo.24.2.389. Int J Oncol. 2004. PMID: 14719116 Review.
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and Rituximab.
Rabascio C, Laszlo D, Andreola G, Saronni L, Radice D, Rigacci L, Fabbri A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G. Rabascio C, et al. Among authors: andreola g. Leuk Res. 2010 Apr;34(4):454-7. doi: 10.1016/j.leukres.2009.07.002. Epub 2009 Aug 3. Leuk Res. 2010. PMID: 19647871 Clinical Trial.
28 results